Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
about
Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodiesThe guanine cap of human guanylate-binding protein 1 is responsible for dimerization and self-activation of GTP hydrolysisBiochemical properties of the human guanylate binding protein 5 and a tumor-specific truncated splice variantPhospholipid scramblase 1 potentiates the antiviral activity of interferonA novel GTP-binding protein hGBP3 interacts with NIK/HGKTetramerization of human guanylate-binding protein 1 is mediated by coiled-coil formation of the C-terminal α-helicesGolgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactorNuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cellsThe helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines.Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitisResistance to Rhabdoviridae Infection and Subversion of Antiviral ResponsesDeterminants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control itExpression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesisNoncytopathic Bovine Viral Diarrhea Virus Inhibits Double-Stranded RNA-Induced Apoptosis and Interferon SynthesisIndependent and Cooperative Antiviral Actions of Beta Interferon and Gamma Interferon against Herpes Simplex Virus Replication in Primary Human FibroblastsAlpha/Beta Interferon Inhibits Cap-Dependent Translation of Viral but Not Cellular mRNA by a PKR-Independent MechanismTriphosphate structure of guanylate-binding protein 1 and implications for nucleotide binding and GTPase mechanismPathophysiological role of guanylate-binding proteins in gastrointestinal diseasesIIGP, a member of the IFN inducible and microbial defense mediating 47 kDa GTPase family, interacts with the microtubule binding protein hook3Insight into temperature dependence of GTPase activity in human guanylate binding protein-1Identification and characterization of interferon-induced proteins that inhibit alphavirus replicationIIGP1, an interferon-gamma-inducible 47-kDa GTPase of the mouse, showing cooperative enzymatic activity and GTP-dependent multimerizationCytokine-related genes identified from the RIKEN full-length mouse cDNA data setExpressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.Analyses of murine GBP homology clusters based on in silico, in vitro and in vivo studies.Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus.Genomic analysis of the host response to hepatitis B virus infection.Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner.Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice.Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis.Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γPathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differencesEvolutionary perspective on innate immune recognition.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.Nonstructural protein 1 of influenza A virus interacts with human guanylate-binding protein 1 to antagonize antiviral activityDimerization and its role in GMP formation by human guanylate binding proteins.Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii.Murine guanylate-binding protein: incomplete geranylgeranyl isoprenoid modification of an interferon-gamma-inducible guanosine triphosphate-binding proteinPulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage.
P2860
Q24293202-042D725C-D1FA-4FC2-9E9C-126B516AA6E8Q24296252-75AADB90-05E6-450D-AECE-F210591EB565Q24300925-0A9FB0E3-2E8C-4460-A788-FEAB7869F6F9Q24301128-D32EEB3E-D9C4-4D46-B094-4E8E137CE24DQ24311631-DC5C41E0-D9CB-46D0-8A46-9DAC5CD46B65Q24323235-DD3F50D9-FEFA-4A44-81EF-DB8E77C881FCQ24529563-45484B12-5CE7-45EB-8A59-09F629D7B28DQ24530727-A1CE08DB-853F-48C0-8DB4-B327EF4619D7Q24534479-B4F68E47-65D9-4D6A-AA1D-64FC193AC5FBQ24671093-C3977665-E2DB-48C7-915F-85FAD42F4520Q26801290-3E2CC24C-3ECD-466E-A0D6-C6CE8D36574EQ27321401-1A841F32-1C30-49AE-9437-1C6C433DCCEDQ27469667-0E592379-E309-4F97-BEAA-64385F20FEBFQ27469798-2AAEF213-4007-4DC6-90B6-2D15AE8FE41EQ27485444-D54B91D5-DA4D-4389-805B-55FCEFF1898EQ27485456-18932104-A4FD-4DAD-B660-CFBC2C336F3FQ27626880-BCACAE47-B817-4FAF-A571-8BAD1E5B5521Q28078361-7861D9B4-9664-4010-9FC1-F4C5EA3B2D44Q28255726-1C65E654-F194-4832-BAE3-7E143B43B8EEQ28481244-AB421C72-84F6-48B1-A331-139F2C78C51CQ28506953-82AAD429-70D2-4C8B-AE8D-F86052D70EFEQ28595035-9520354A-519F-498A-A98C-9CF00C93A32BQ30805616-C8B26A2F-00BF-44CE-95AC-C625E2F7AEA0Q33257453-CC4A9A75-FBD4-4AA0-B20C-BCA4677E3BFBQ33327569-B87C6B83-AC62-415C-A5A8-0D9A6C0D5818Q33490124-2E68511C-2D1C-4D32-A865-C70911643F91Q33496779-D2D0E5A8-ABBF-4CE0-9DA9-F5130B0F96EAQ33696514-21F97D2E-F2EE-4A6E-B181-B31701543257Q33769297-F54A9BC2-13BD-487E-B01F-AF1EC8894B90Q33830630-206D338A-ACCB-4C28-BFA4-66231764BBE2Q33879907-A0AF6972-ED8C-43C2-8424-9544E1C8380DQ33886711-54D428B5-6568-4E95-8F6E-8B52EC58F43FQ34190622-75DEA420-2E2B-460D-8ED0-D9854128FABDQ34449973-01DBFDF9-F59F-4525-B86F-F9363526F98BQ34465900-F0F2E626-819D-4623-81E5-9EECE73AC96CQ34584607-E67D4005-BC2F-4B77-AC16-D05E80DD756AQ34590697-616379D8-A154-43F3-B1C4-76550572C6E5Q34697891-53AF74F2-D565-4397-9204-3FB9950CC951Q34728624-B2FB0908-D056-4B04-9101-BCD750A0CE72Q35025824-CB2747EC-6225-4E92-942A-52F9B6A86C75
P2860
Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Interferon-induced guanylate b ...... nd encephalomyocarditis virus.
@ast
Interferon-induced guanylate b ...... nd encephalomyocarditis virus.
@en
type
label
Interferon-induced guanylate b ...... nd encephalomyocarditis virus.
@ast
Interferon-induced guanylate b ...... nd encephalomyocarditis virus.
@en
prefLabel
Interferon-induced guanylate b ...... nd encephalomyocarditis virus.
@ast
Interferon-induced guanylate b ...... nd encephalomyocarditis virus.
@en
P2093
P356
P1433
P1476
Interferon-induced guanylate b ...... nd encephalomyocarditis virus.
@en
P2093
P356
10.1006/VIRO.1999.9614
P407
P577
1999-03-01T00:00:00Z